AVZO-023 drug page Clinical trials

Trials with AVZO-023

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
1Recruiting
1Countries
380Planned patients

Showing 1–1 of 1

ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors
Recruiting Phase 1 380 patients NCT06998407

This study, the first clinical trial of AVZO-023, aims to determine the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, maximum tolerated dose, and anti-tumor effects of AVZO-023 in patients with advanced solid tumors. AVZO-…

United States Aug 2025 – Aug 2030 Interventional

Where the recruiting trials are